We are live on ! Find out more
AGN

Allergan plc
AGN

Delisted

AGN was delisted on the 8th of May, 2020.

674 hedge funds and large institutions have $39.7B invested in Allergan plc in 2014 Q2 according to their latest regulatory filings, with 103 funds opening new positions, 272 increasing their positions, 223 reducing their positions, and 52 closing their positions.

New
Increased
Maintained
Reduced
Closed

98% more first-time investments, than exits

New positions opened: 103 | Existing positions closed: 52

77% more call options, than puts

Call options by funds: $1.11B | Put options by funds: $627M

22% more repeat investments, than reductions

Existing positions increased: 272 | Existing positions reduced: 223

19% more capital invested

Capital invested by funds: $33.3B → $39.7B (+$6.35B)

15% more funds holding in top 10

Funds holding in top 10: 7384 (+11)

7% more funds holding

Funds holding: 628674 (+46)

Holders
674
Holders Change
+46
Holders Change %
+7.32%
% of All Funds
19.36%
Holding in Top 10
84
Holding in Top 10 Change
+11
Holding in Top 10 Change %
+15.07%
% of All Funds
2.41%
New
103
Increased
272
Reduced
223
Closed
52
Calls
$1.11B
Puts
$627M
Net Calls
+$482M
Net Calls Change
+$56.9M
Name Holding Trade Value Shares
Change
Change in
Stake
BS
226
Bow Street
New York
$13.2M +$2.62M +12,668 +27%
CIBC Private Wealth Group
227
CIBC Private Wealth Group
Georgia
$13.2M -$12.2K -59 -0.1%
BPB
228
Badgley, Phelps & Bell
Washington
$13.1M -$250K -1,207 -2%
AIA
229
Avalon Investment & Advisory
Texas
$13.1M +$409K +1,975 +3%
PWPCM
230
Perella Weinberg Partners Capital Management
New York
$12.7M +$11.8M +57,009 New
RI
231
Redwood Investments
Massachusetts
$12.7M -$7.16M -34,577 -38%
VanEck Associates
232
VanEck Associates
New York
$11.9M -$1.97M -9,510 -15%
Asset Management One
233
Asset Management One
Japan
$11.8M -$1.84M -8,869 -14%
VRS
234
Virginia Retirement Systems
Virginia
$11.7M +$4.55K +22 +0%
HSBC Holdings
235
HSBC Holdings
United Kingdom
$11.6M -$886K -4,281 -8%
DCM
236
Decatur Capital Management
Georgia
$11.4M -$104K -500 -1%
IGM
237
Incline Global Management
New York
$11.3M +$2.12M +10,230 +25%
WJA
238
Williams Jones & Associates
New York
$11.2M -$7.22M -34,860 -41%
RAM
239
Riggs Asset Management
Pennsylvania
$11.2M +$438K +2,113 +4%
ASRS
240
Arizona State Retirement System
Arizona
$11.2M -$2.24M -10,800 -18%
Adage Capital Partners
241
Adage Capital Partners
Massachusetts
$11.2M +$10.4M +50,000 New
KCM
242
Kingdon Capital Management
New York
$11.1M +$4.59M +22,150 +80%
OCM
243
Oskie Capital Management
New York
$11.1M +$3.71M +17,941 +56%
NIP
244
Nicholas Investment Partners
California
$11.1M +$5.35M +25,840 +108%
DM
245
Delphi Management
Massachusetts
$10.9M -$3.94M -19,025 -28%
GIBU
246
Gulf International Bank (UK)
United Kingdom
$10.8M +$10.1M +48,606 New
MRCM
247
M&R Capital Management
New Jersey
$10.8M +$817K +3,946 +9%
B
248
BP
United Kingdom
$10.7M
MCM
249
Moore Capital Management
New York
$10.6M +$8.77M +42,345 +846%
GL
250
GLG LLC
New York
$10.4M +$1.04M +5,000 +12%

AGN Hedge Fund Activity: Q2 2014 in Review

674 of the 3,481 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN) for Q2 2014, worth a combined $39.7B — up 19% from $33.3B a quarter earlier.

Buyers outnumbered sellers: 103 funds opened new AGN positions and 52 closed out — a net gain of 51 holders — while 272 added to existing stakes and 223 trimmed.

The largest buyer was Jana Partners, adding an estimated $363M. The largest seller was York Capital Management Global Advisors, exiting entirely with an estimated $198M sold.

  • 674 institutional investors held Allergan plc (AGN) as of Q2 2014, up from 628 in Q1 2014.
  • Funds reported $39.7B of Allergan plc stock for Q2 2014, up 19% quarter-over-quarter.
  • 103 funds opened new Allergan plc positions in Q2 2014 and 52 closed out, a net change of +51 holders.
  • The largest Allergan plc buyer in Q2 2014 was Jana Partners, an estimated $363M added.
  • The largest Allergan plc seller in Q2 2014 was York Capital Management Global Advisors, an estimated $198M sold.

Based on aggregated 13F filings for Q2 2014.